Final Agenda Released for Oxford Global’s 4th Annual Clinical Development and Trials Asia Congress

Oxford Global Conferences are delighted to announce the release of the final agenda for the upcoming 4^th Annual Clinical Development & Trials Asia Congress and co-located 5^th Annual Pharma R&D World Asia Congress, taking place on the 27^th & 28^th January 2015 in Shanghai, China. Attended by over 170 industry leaders, the 4th Annual Clinical Development and Trials Asia Congress will offer invaluable insights into the changing regulatory environment in China and surrounding regions and cover successful strategies and innovative technologies in enabling clinical development and clinical trial management.

 

As well as over 25 presentations in streams focusing upon Clinical Development Activities & Clinical Outsourcing Strategies, Enabling Technologies for Drug Development and Personalised Medicine (Featured Technology Stream), Clinical Trials Management Strategies in Asia and Asia Pacific Regions and Innovation Strategies to Advance R&D in Asia, the Congress will also feature Panel Discussions covering the following topics:

 

        ·  Will Asia "Produce" in Regards to Drug Development?

        ·  Regulatory Updates for Registration for Multinational Clinical Trials - China, Japan, South Korea & Singapore

        ·  Innovation Strategies to Advance R&D in Asia

        ·  CRO - R&D Collaborations and Business Models

 

Our dedicated research into the field ensures that we secure the very best quality speakers from top pharma companies and academic institutes to share their inspirational work with the conference attendees. We have ensured that every speaker has a unique story to bring to the audience and that they will present the latest, most exciting work – highlighting any pitfalls they have made along the way. Confirmed speakers include:

 

• Zhengqing Li, VP and Head of China Development MSD
• Cezary Statuch, Vice President of R&D, Bristol-Myers Squibb, China
• Dan Paulson, Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women’s HealthCare, Bayer HealthCare Company Limited Global R&D Centre
• Oliver Kong, Senior Director, Clinical Development Oncology, Celgene Corporation
• Yong-jiang Hei, Executive Medical Director, Amgen China
• Jessie Gu, Head, Translational Medicine China, Novartis Institute for Biomedical Research, China

 

To view the full list of speakers, please visit http:///who-is-speaking/

 

With just over a month to go until the 4^th Annual Clinical Development and Trials Asia Congress and co-located 5^th Annual Pharma R&D World Asia Congress, download the finalised agenda by visiting http:///download-agenda-marketing/

 

Registration for the 4^th Annual Clinical Development and Trials Asia Congress will shortly be closing due to a limited number of spaces now remaining. To find out further information regarding the Congresses and to book, please contact Steph Punfield on s.punfield@oxfordglobal.co.uk or call +44 (0)1865 248455.